Nabla, a leading provider of clinical AI assistants, has raised an additional $70 million in Series C funding, which brings total funding to $120 million, according to a company news release. The ...

The rolling back of a nursing home staffing level mandate could lead to 13,000 preventable deaths, according to a June 3 letter written by public health economists and researchers. Addressing ranking ...

The state of New York plans to invest $1 billion in SUNY Downstate’s hospital in New York City’s Brooklyn borough. The investment comes after months of community engagement led by SUNY Downstate’s ...

Here are three of the most recent recalls reported to the FDA in June: Q’Apel Medical recalled its Hippo 072 aspiration system, including the Cheetah delivery tool and aspiration tubing, following a ...

Florida Attorney General James Uthmeier has taken legal action against Contec, a Chinese medical devicemaker, and Miami-based reseller Epsimed, alleging the companies sold patient monitors that pose ...

Hospital labor costs related to drug shortage management have significantly increased, from $359 million in 2019 to $894 million in 2024 — a nearly 150% increase, according to a Vizient report ...

An Orlando, Fla.-based Advent Health surgeon has performed a prostatectomy via transcontinental robotic telesurgery — the first of an FDA-approved clinical trial to test the technology, according to a ...

As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

Anthony Law, MD, PhD, an assistant professor in the department of otolaryngology at Atlanta-based Emory University School of Medicine, has developed an AI model to detect throat cancer in a patient’s ...

Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,0001 fatalities expected in 2025. While the burden of this disease is significant, advancements in ...

The FDA has delayed its decision to approve a new treatment for hereditary angioedema, citing a heavy workload and limited resources. The drug, sebetralstat, developed by Kalvista Pharmaceuticals, was ...

Mark Cuban’s Cost Plus Drug Co. and virtual care provider 9amHealth have partnered to offer obesity medications through a new program targeting self-insured employers. Under the partnership, 9amHealth ...